The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2026

Filed:

May. 03, 2024
Applicant:

Probioticsmart, Llc, Menomonie, WI (US);

Inventors:

Daniel J. Dubourdieu, Limerick, ME (US);

Rajiv Lall, Menomonie, WI (US);

Assignee:

Probioticsmart, LLC, Menomonie, WI (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/315 (2006.01); A23K 10/16 (2016.01); A23K 20/111 (2016.01); A23K 20/20 (2016.01); A23K 50/75 (2016.01); A23L 33/00 (2016.01); A23L 33/105 (2016.01); A23L 33/16 (2016.01); A61K 31/192 (2006.01); A61K 31/198 (2006.01); A61K 31/353 (2006.01); A61K 31/385 (2006.01); A61K 31/7008 (2006.01); A61K 31/716 (2006.01); A61K 33/04 (2006.01); A61K 35/748 (2015.01); A61P 3/02 (2006.01); A61P 37/06 (2006.01); A61P 39/06 (2006.01); C07F 3/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/315 (2013.01); A23K 10/16 (2016.05); A23K 20/111 (2016.05); A23K 20/30 (2016.05); A23K 50/75 (2016.05); A23L 33/105 (2016.08); A23L 33/16 (2016.08); A23L 33/40 (2016.08); A61K 31/192 (2013.01); A61K 31/198 (2013.01); A61K 31/353 (2013.01); A61K 31/385 (2013.01); A61K 31/7008 (2013.01); A61K 31/716 (2013.01); A61K 33/04 (2013.01); A61K 35/748 (2013.01); A61P 3/02 (2018.01); A61P 37/06 (2018.01); A61P 39/06 (2018.01); C07F 3/06 (2013.01); A23V 2002/00 (2013.01);
Abstract

The invention is directed to tetrahydrocurcuminoid-metal complexes. The complexes can be included in compositions that further include additional nutraceutical antimicrobials, antioxidants, and immune boosters. The tetrahydrocurcuminoid-metal complexes can be administered to animals to increase animal health, reduce stress, reduce oxidative stress, maintain health, improve health, improve immunity, improve vaccination efficacy, increase feed conversion rate, decrease pro-inflammatory cytokine levels, or any combination thereof in an animal. The tetrahydrocurcuminoid-metal complexes of the invention exhibit enhanced bioavailability relative to the individual, non-complexed components.


Find Patent Forward Citations

Loading…